HowtoplananimmunoprecipitationofyourGFP-fusionproteinwhenusingtheChromoTekGFP-Trap®
PreambleThisdocumentprovidespracticalinformationonhowtoapplytheChromoTekGFP-Trap®forimmunoprecipitation.
IntroductionTheChromoTekGFP-Trap®isbasedonaGFP-bindingproteinderivedfromanAlpacasinglevariabledomainantibody,alsocalledVHHornanobody(figure1).TheGFP-TraphasparticularpropertiesandprovidessomeadvantagesovertrADItionalIgGantibodieswhenappliedinimmunoprecipitations.
PlanningoftheexperimentTherearesomeexperimentalaspectsthatyoushouldconsiderwhenplanningimmunoprecipitationofyourGFP-fusionproteinofinterestusingtheChromoTekGFP-Trap®.Below,weguideyouthrougheachstep.
Thereare3matricesavailable:
Pre-clearing:Pre-clearingisanoptionalsteptoremoveproteinsorDNAwhichbindnon-specificallytothesolid-phasesupport.Itincludestheincubationofthecellextractwithplainbeads(e.g.bindingcontrolagarosebeads)beforeperformingtheactualimmunoprecipitationexperimentwiththeGFP-Trap.Aftersuccessfulpre-clearing,non-specificproteinsorothercomponentswillnotbeco-purifiedwiththeproteinofinterest. CRAPome:Bynature,everymatrixandbindingmoleculemaynonspecificallybindsomeproteinsresultinginproteinbackground.Scientistshaveestablishedtheinternet-baseddatabaseCRAPomeatwww.crapome.org.Thisdatabasestoresandannotatesnegativecontrolsgeneratedbytheproteomicsresearchcommunity.CRAPomehelpstodeterminethebackgroundcontaminants--forexample,proteinsthatinteractwiththesolid-phasesupport,affinityreagentorepitopetag. Specificity-WhatfluorescentproteinsarecapturedbytheGFP-Trap®TheGFP-Trap®specificallybindstomostofthecommonGFPderivatives:
Feature | Agarosebeads | Magneticagarosebeads | Magneticbeads |
Matrix | Agarose,4%highlycross-linked | Agarose,6%cross-linked | Silica,non-porous |
Particalsize | 45-165μm | 20-40μm | 0.5-1μm |
Bindingcapacity | 2-3μgper10μlbeadslurry | 2-3μgper10μlbeadslurry | 0.5μgper10μlbeadslurry |
Magnetic | no | yes | yes |
TheChromoTekGFP-Trap®onlybindsproperlyfoldedactiveGFP.Itisbelievedthatthisisbecausethatnanobodybindstoathree-dimensionalepitopeofGFP.Thenanobody’selongatedCDR3(complementaritydeterminingregion3)allowstoreachintocleftsandenzymaticcentersofproteins,whicharenotaccessIBLetoconventionalantibodiesbutresultsinverystrongbindingandverylowdissociationconstantsofthisGFPnanobody.Thereforethatanti-GFPnanobodyisnotsuitableforproteindetectioninWesternBlots.ForWesternBlotdetectionofGFP(fusionproteins)ChromoTekrecommendsthetraditionalantibodyanti-GFPantibody3H9(ratmonoclonal,seecomplementaryproducts). Controls–WhatcontrolsshouldIconducttovalidatetheexperimentaldata?Belowfindsomesuggestionsbyapplication:ForImmunoprecipitation(IP):•GFP-Trap®forIPofGFP-fusionsandanon-relevantNano-Trapasnegativecontrol,e.g.Myc-Trap®,GST-TraporMBP-TrapForCo-Immunoprecipitation(Co-IP)ofproteincomplexAB: CellLysis–Whattoconsiderwhenpreparingacelllysate?Lysisbuffers:•Anon-denaturinglysisbufferissuitableforCo-IP,becauseproteinswillremainintheirnativeconformation•TheRIPA(RadioImmunoprecipitationAssay)buffermightdenatureproteinsordisruptproteincomplexesInhibitors:•Addproteaseinhibitorstopreventproteolysis!•Preserveposttranslationalmodificationsofyourproteinandadde.g.phosphataseinhibitors!•Preventdegradationofyourproteinbykeepingyoursamplesonice! Immunoprecipitation–BindingoftheGFP-fusionSincetheGFPbindingproteiniscovalentlycoupledtothebeads’surface,theGFP-Trap®beadsareready-to-useandcanbedirectlyaddedtothepreparedlysate.TheaffinityofGFP-nanobodyisinthepicomolarrange,thereforedepletionofGFP-fusionscanbecompletedwithin5-30minutes. BuffercompatibilityoftheGFP-Trap®forbindingandwashingTheGFP-Trap®iscompatiblewithmostwashbuffersandstableunderharshconditionsincluding:•Upto1MNaCland8MUrea•Upto0.2%SDSand2%NP-40 ElutionstrategiesTheelutionoftheboundGFP-fusionproteinbyacompetitivepeptide,whichreplacestheGFP-fusionproteindoesn’twork.Also,theadditionofchaotropiccompoundslikeureadon’telutethebondGFP-fusionproteinastheGFP-Trap®worksunderdenaturingconditions.Wethereforerecommendtoelutewith: •SDS,e.g.SDSsamplebuffer,isaveryeffectivewaytoelutetheboundGFP-taggedprotein.TheelutionresultsindenaturedGFP-fusions.•0.2MglycinepH2.5 AlternativelyyoumayelutewithglycineatpH2.5.ItisrecommendedtorepeatthiselutionstepasthepHshiftelutionworksincompletely.Therepetitionwillimprovetheelutionefficiency. Veryimportant:Don’tforgettoneutralizeproteinsimmediatelyafterelution! Asanalternativetoaboveelutionoptions,aproteasecleavagesitebetweenGFPandthefusionproteincanbeintroduced.Thisoptionisrecommendediflessstableproteinshavebeenboundorifyouwanttoenrichyournativeproteinofinterest.FurThermore,considerwhetheryoureallyneedtoelutetheboundproteinofinterestfromthebeadsratherthanconductthedownstreamanalysis\"on-bead”:•Proteinscanbedigestedwhenstillcoupledtothebeadsforsubsequentmassspectrometryanalysis.•Enzymaticactivityassayscanbeperformedwhenstillcoupledtothebeadsiftheactivecenterisnotblocked. ReproducibilityTheGFP-Trap®isasmall,solubleandstablesinglepolypeptidechainthatisrecombinantlyexpressedinbacteria.Thisincombinationwithqualitycontrolmakesitsproductionrobustandreproducibleforreliableresults. SelectedReferencestointroduceNanobodiesandtheirapplications:NanobodiesasprobesforproteindynamicsinvitroandincellsDmitriev,O.Y.,Lutsenko,S.andMuyldermans,S.in:JournalofBIOLOGicalChemistry,2015–jbc-R115. AversatilenanotrapforbiochemicalandfunctionalstudieswithfluorescentfusionproteinsRothbauer,U.,Zolghadr,K.,Muyldermans,S.,Schepers,A.,Cardoso,M.C.,Leonhardt,H.in:MolCellProteomics,2008Feb;7(2):282-9.Epub2007Oct21 Nanobody-basedproductsasresearchanddiagnostictoolsDeMeyer,T.,Muyldermans,S.andDepicker,A.in:TrendsinBiotechnology,2014May;32(5):263-270; Beneficialpropertiesofsingle-domainantibodyfragmentsforapplicationinimmunoaffinitypurificationandimmuno-perfusionchromatographyVerheesenP.,TenHaaftM.R.,LindnerN.,VerripsC.T.,deHaardJ.J.W.in:Biochim.Biophys.Acta,2003;1624(1–3):21–28 Ahighlyspecificgoldnanoprobeforlive-cellsingle-moleculeimagingLeduc,C.,Si,S.,Gautier,J.,Soto-Ribeiro,M.,Wehrle-Haller,B.,Gautreau,A.,.Giannone,G.,Cognet,L.&Lounis,B.in:Nanoletters,2013:13(4),1489-1494. Nanobody-basedchromatinimmunoprecipitation.Duc,T.N.,Hassanzadeh-Ghassabeh,G.,Saerens,D.,Peeters,E.,Charlier,D.,&Muyldermans,S.in:SingleDomainAntibodies:MethodsandProtocols,2013:491-505
Fluorescentprotein | GFP-Trap® | Fluorescentprotein | GFP-Trap® | |
(e)GFP | √ | (e)Citrine | √ | |
tagGFP2 | √ | AcGFP | √ | |
turboGFP | - | SuperfolderGFP | √ | |
mClover | √ | mCerulean | √ | |
YFP | √ | pHluorin | √ | |
CFP | √ | GFPS65T | √ | |
Venus | √ | - | - |
Productname | Size | Code |
GFP-Trap®A ▶coupledtoagarosebeads | 10rxns(250µlresin) | gta-10 |
20rxns(500µlresin) | gta-20 | |
100rxns(2.5mlresin) | gta-100 | |
200rxns(5mlresin) | gta-200 | |
400rxns(10mlresin) | gta-400 | |
GFP-Trap®AKit ▶GFP-Trap®A ▶incl.lysiswashandelutionbuffers | 20rxns(500µlresin) | gtak-20 |
GFP-Trap®MA▶coupledtomagneticagarosebeads | 10rxns(250µlresin) | gtma-10 |
20rxns(500µlresin) | gtma-20 | |
100rxns(2.5mlresin) | gtma-100 | |
200rxns(5mlresin) | gtma-200 | |
400rxns(10mlresin) | gtma-400 | |
GFP-Trap®MAKit ▶GFP-Trap®MA ▶incl.lysis,washandelutionbuffers | 20rxns(500µlresin) | gtmak-20 |
GFP-Trap®M ▶coupledtomagneticparticles | 10rxns(250µlresin) | gtm-10 |
20rxns(500µlresin) | gtm-20 | |
100rxns(2.5mlresin) | gtm-100 | |
200rxns(5mlresin) | gtm-200 | |
400rxns(10mlresin) | gtm-400 | |
GFP-Trap®MKit▶GFP-Trap®M▶incl.lysis,washandelutionbuffers | 20rxns(500µlresin) | gtmk-20 |
GFP-multiTrap®▶black96wellplate | 96rxns(1plate) | gtp-96 |
480rxns(5plate) | gtp-480 | |
GFP-Trap®▶uncoupledprotein | 250µl | gt-250 |
Spincolumns | 10units | sct-10 |
20units | sct-20 | |
50units | sct-50 | |
Bindingcontrol▶agarosebeads | 500µl(20rxns) | bab-20 |
Bindingcontrol▶magneticagarosebeads | 500µl(20rxns) | BMAb-20 |
Bindingcontrol▶magneticparticles | 500µl(20rxns) | bmp-20 |
GFPantibody(3H9)▶ratmonocional | 100µl | 3H9 |